170 filings
DEF 14A
RCEL
AVITA Medical Inc
Definitive proxy
23 Apr 24
5:09pm
ARS
2023 FY
RCEL
AVITA Medical Inc
23 Apr 24
Annual report to shareholders
5:06pm
8-K
RCEL
AVITA Medical Inc
11 Apr 24
AVITA Medical Updates Expected First Quarter 2024 Revenue
5:05pm
PRE 14A
RCEL
AVITA Medical Inc
Preliminary proxy
4 Apr 24
5:18pm
10-K
2023 FY
RCEL
AVITA Medical Inc
Annual report
22 Feb 24
4:05pm
8-K
99x3oj63
22 Feb 24
AVITA Medical Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance
4:02pm
8-K
l21vdnt78zsiutvt
10 Jan 24
AVITA Medical Announces Preliminary 2023 Financial Highlights, Provides 2024 Financial Guidance and Business Update
4:05pm
8-K
rhw djvel83c1pdtr
9 Nov 23
AVITA Medical Reports Third Quarter Financial Results with 51% Revenue Growth over the Same Period the Prior Year
4:09pm
8-K
pkcz4dev
23 Oct 23
Departure of Directors or Certain Officers
4:36pm
8-K
jcgl2iure 9dkj
18 Oct 23
Preliminary commercial revenue of $13.5 million for the third quarter 2023; full year 2023 guidance confirmed
9:07am
424B5
25tie 2k7wamdy15by
18 Oct 23
Prospectus supplement for primary offering
9:04am
8-K
4mye j2e5f4
2 Oct 23
Other Events
8:56am
8-K
c47g 8nl96im
10 Aug 23
AVITA Medical Reports Second Quarter Financial Results
4:05pm
S-8
5wutj8x24y1oeqd2i
30 Jun 23
Registration of securities for employees
4:27pm
8-K
1vikof ipf33q5
26 Jun 23
Regulation FD Disclosure
8:11am
8-K
fhb843cqviok o475xxa
15 Jun 23
AVITA Medical Announces Appointment of David O’Toole as Chief Financial Officer
7:51pm
8-K
6wqx5aa5gwqy7 ar
7 Jun 23
Departure of Directors or Certain Officers
1:29pm
ARS
52kpi6ik
30 May 23
Annual report to shareholders
3:45pm